Techcyte

Labopat Diagnosticos® is now live with Techcyte Fusion® across histology and cervical cytology workflows.

Based in Mexico, Labopat has nearly 40 years of experience delivering highly specialized diagnostic services rooted in technology, ethics, and patient care.

Their implementation of Fusion reflects a growing global shift toward unified digital pathology platforms that support AI-based workflows, remote review, and collaboration as laboratories respond to increasing demand and workforce challenges.

We’re proud to support Labopat as they continue advancing digital pathology across Mexico.

Read the full announcement ↓
https://na2.hubs.ly/H05Ll470

Aira Matrix AI is now integrated into Techcyte Fusion AP.

The integration brings:
→ AIRAProstate for AI-assisted prostate pathology workflows
→ AIRAQc for whole slide image quality control

Both solutions integrate directly into Fusion AP as Techcyte Flows, helping laboratories access AI within a unified digital pathology workflow.

Learn more: https://hubs.ly/Q04hfmPW0

Are you at the API - The Association for Pathology Informatics, PI Summit?

Visit Techcyte at Booth #2 to experience Techcyte Fusion®, our unified digital pathology platform designed to support histology, cytology, bacteriology, parasitology, and hematology workflows.

See our clean, ultra-fast viewer in action and meet the team behind Fusion 👉 booth #2

Choosing a digital pathology platform is one decision.
Choosing the infrastructure behind it is quite another.

As slide volumes grow and workflows become more connected, many labs are facing new questions around scalability, maintenance, data governance, and long-term flexibility.

Join us for an upcoming webinar exploring SaaS vs. on-premise models in digital pathology and the tradeoffs that can shape your lab for years to come.

→ May 21st | 10 am MT

Reserve your spot: https://hubs.ly/Q04gNY0y0

Today we celebrate the cytotechnologists, cytopathologists, and laboratory teams helping drive the future of cytology through digital workflows and innovation.

We’re proud to support the future of cytology through digital pathology and AI-assisted workflows designed to help laboratories adapt, scale, and innovate.

Happy National Cytotechnology Day to the professionals advancing pathology every day.

Radiology went digital decades ago. The technology worked, but the workflow consequences were harder.

As pathology continues its digital transition, there’s an opportunity to learn from radiology’s experience with burnout, workload expansion, workflow fragmentation, and productivity pressure.

Our latest blog explores what pathology should take from those lessons, and what labs should be thinking about now as they scale digital workflows and AI.

Read the blog → https://hubs.ly/Q04g85XR0

Techcyte and Biobase have partnered to help laboratories unlock the full potential of their clinical data.

By connecting Techcyte Fusion® with Biobase’s AI-driven data discovery platform, labs can securely participate in research and commercial collaborations using de-identified pathology data and samples, while maintaining full control over access and participation.

The goal: help labs expand the value of digital pathology and create new opportunities from existing clinical data.

Read more about it → https://hubs.ly/Q04fT5QV0

We’re excited to share that a poster presentation from the Contra Costa County Public Health Laboratory evaluating AI-assisted O&P workflows using Techcyte’s parasitology suite has been accepted for the Association of Public Health Laboratories (APHL) Annual Conference.

The study explores how AI-assisted screening can be applied across trichrome and wet mount workflows in a public health laboratory setting, including observations related to workflow efficiency, turnaround time, and staff experience.

📍 Techcyte will be at Booth 201 in Baltimore this week

If you’re attending, stop by to learn more about our digital parasitology solutions supporting trichrome, wet mount, and MAF workflows.

Read more about the study: https://hubs.ly/Q04fgVTv0

We’re excited to share a new milestone for Techcyte.

Today, we're happy to announce a $15 million capital raise led by Van Tuyl Companies, with participation from Mayo Clinic and Zoetis.

This investment supports the continued growth of our AI-powered digital pathology platform and reflects increasing demand for scalable, digital solutions in pathology. We’re grateful to our investors, partners, and customers for being part of this journey.

See what this means for what’s ahead for Techcyte! → https://hubs.ly/Q04f1Ldb0